When a company such as ASTX splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the ASTX split history from start to finish, an original position size of 1000 shares would have turned into 1500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ASTX shares, starting with a $10,000 purchase of ASTX, presented on a split-history-adjusted basis factoring in the complete ASTX split history.
ASTX -- use the split history when considering split-adjusted past price performance.

About ASTX

Astex Pharmaceuticals is engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. Co. sells Dacogen®, a product approved by the U.S. FDA for the treatment of myelodysplastic syndromes, and approved by the European Commission for the treatment of adult patients with newly diagnosed de novo or secondary acute myeloid leukemia who are not candidates for standard induction chemotherapy. At Dec 31 2012, Dacogen was approved for sale in 35 additional countries outside of the U.S. and Europe. Also, Co.'s Astex Therapeutics Limited subsidiary has a pipeline of drugs at various stages of clinical, pre-clinical, and early discovery development. According to our ASTX split history records, ASTX has had 1 split.

ASTX Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved